HAYES CHRISTOPHER G. (General Counsel) sold 2.4% of their position (4.32K shares) of VERRICA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $2.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/18/2025ACC: 0001415889-25-008505
Officer· General Counsel
Since Feb 2020
+245.69K
Net shares
Net buyer
$2.8K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
250K acquired · 4.32K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.32K
Price / share
$0.65
Trade value
$2.80K
% of position
2.4%
3/17/2025
180.77K→176.46K
Total
Net shares
−4.32K
Net value
-$2.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2025 | S · Sale | −4.32K | $0.65 | $2.80K | 2.4% | 180.77K | 176.46K |
| Total | −4.32K | -$2.80K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
250K shares
Shares
+250K
Strike price
0.89
Held after
250K
Exercisable
—
3/14/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock250K shares | 3/14/2025 | A · Award | +250K | 0.89 | — | 250K |